Evaluation of treatment response by Hopkins criteria on18F FDG PET-CT in patients of non-small cell lung cancer and its comparison with PERCIST response criteria

被引:0
|
作者
Dang, Shreya [1 ]
Shivdasani, Divya [1 ]
Pereira, Melvika [1 ]
Singh, Natasha [1 ]
Rungta, Rachita [1 ]
Roy, Debdip [1 ]
Kesariya, Jugal [1 ]
机构
[1] PD Hinduja Natl Hosp & Med Res Ctr, Dept Nucl Med & PET CT, Veer Savarkar Marg, Mumbai 400016, India
关键词
evaluation; FDG PET; Hopkins; NSCLC; PERCIST; response; POSITRON-EMISSION-TOMOGRAPHY;
D O I
10.1097/MNM.0000000000001756
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Aim To assess treatment response on FDG PET-CT in NSCLC patients by visual Hopkins score compared to PERCIST criteria and its potential for prognostication (or its correlation with survival).Methods Forty-four NSCLC patients with baseline and post-treatment FDG PET-CT scans were included, and interpreted using Hopkins and PERCIST criteria classifying patients into responders and non-responders. PERCIST-based CMR and PMR, and Hopkins Scores 1,2,3 were classified responders. PERCIST-based SD and PD and Hopkins scores 4,5 were classified as non-responders. Patients were followed upto 24 months after treatment completion. Cohen kappa for inter-criteria agreement and Kaplan Meir curve for overall survival (OS) analysis done.Results Out of 44 patients, PERCIST classified 27 (61.3%) as responders and 17 (38.6%) as non-responders, whereas Hopkins classified 12 patients (27.3%) as responders and 32 (72.7%) as non-responders. Inter-criteria agreement was low (kappa=0.19) with discordance in 45.5% of patients. Eighteen of 20 discordant cases were non-responders on Hopkins and responders on PERCIST, of which 88.8% were non-responders on follow-up as predicted by Hopkins. PERCIST responders had OS of 96.4% and 64.3% at 9 and 24 months, respectively, while non-responders OS was 93.5% and 40.2% at 9 and 24 months, respectively (P-value = 0.049). However, responders on Hopkins had OS of 100% at 24 months, whereas non-responders had OS of 93.5% and 51.5% at 9 and 24 months, respectively (P-value = 0.232).Conclusion Semi-quantitative PERCIST and visual Hopkins criteria show low inter-criteria agreement, with visual criteria better-predicting survival in patients of NSCLC.
引用
收藏
页码:1038 / 1045
页数:8
相关论文
共 50 条
  • [21] Comparison between PERCIST and EORTC criteria in the evaluation of response to immune check-point inhibitors in Non-Small Cell Lung Cancer (NSCLC) patients
    Piva, R.
    Rossi, G.
    Bauckneht, M.
    Genova, C.
    Ceriani, V.
    Rijavec, E.
    Barletta, G.
    Biello, F.
    Calamia, I.
    Dal Bello, G.
    Di Stefano, R.
    Sambuceti, G.
    Grossi, F.
    Morbelli, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S674 - S674
  • [22] Role of 18F-FDG PET in Assessment of Response in Non-Small Cell Lung Cancer
    Hicks, Rodney J.
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50 : 31S - 42S
  • [23] Comparison of early response assessment with Ga-68 FAPI PET/CT and F-18 FDG PET/CT in Non-small cell lung cancer
    Mittal, Bhagwant
    Purohit, Priyavrat
    Kumar, Rajender
    Singh, Harmandeep
    Shukla, Jaya
    Bal, Amanjit
    Singh, Navneet
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [24] Proposal of a New 18F-FDG PET/CT Predictor of Response in Rectal Cancer Treated by Neoadjuvant Chemoradiation Therapy and Comparison With PERCIST Criteria
    Maffione, Anna Margherita
    Ferretti, Alice
    Chondrogiannis, Sotirios
    Rampin, Lucia
    Marzola, Maria Cristina
    Grassetto, Gaia
    Capirci, Carlo
    Colletti, Patrick M.
    Rubello, Domenico
    CLINICAL NUCLEAR MEDICINE, 2013, 38 (10) : 795 - 797
  • [25] Comparing response rates using RECIST, EORTC and PERCIST criteria for response evaluation in patients with non-small-cell lung cancer
    Ling, Xueying
    Shang JingJie
    Tang, Yongjin
    Xiao, Zeyu
    Xu, Hao
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [26] Efficacy of 18 F-FDG PET/CT as Response Predictor in Locally Advanced Non-Small Cell Lung Cancer
    Roy, Soumyajit
    Pathy, Sushmita
    Kumar, Rakesh
    Mohanti, Bidhu K.
    Raina, Vinod
    Jaiswal, Anand
    Taywade, Sameer
    Malhotra, Arun
    Thulkar, Sanjay
    Mohan, Anant
    Mathur, Sandeep
    Behera, Digamber
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S687 - S687
  • [27] Radiomic Analysis of FDG PET-CT in Non-Small Cell Lung Cancer
    Albattat, Khamael
    Smith, Rhodri
    Morley, Nicholas
    Marshall, Christopher
    QUALITY OF LIFE RESEARCH, 2023, 32 (SUPPL 1) : S16 - S16
  • [28] 18F-FDG PET-CT SIMULATION FOR NON-SMALL-CELL LUNG CANCER: EFFECT IN PATIENTS ALREADY STAGED BY PET-CT
    Hanna, Gerard G.
    McAleese, Jonathan
    Carson, Kathryn J.
    Stewart, David P.
    Cosgrove, Vivian P.
    Eakin, Ruth L.
    Zatari, Ashraf
    Lynch, Tom
    Jarritt, Peter H.
    Young, V. A. Linda
    O'Sullivan, Joe M.
    Hounsell, Alan R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (01): : 24 - 30
  • [29] Evaluation of early response to chemotherapy in patients with non-small-cell lung cancer by comparison of PET-CT based EORTC and PERCIST criteria and comparison within both criterias using SUV normalized also for body weight
    Rachh, S.
    Singh, N.
    Pereira, M.
    Abhyankar, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S441 - S442
  • [30] Staging and assessment of the response to PET-CT treatment in non-small cell lung carcinoma
    Mendez Garcia, M.
    Brenes, M. A.
    Gomez, R.
    Soriano, M.
    Torrente, M.
    Maximiano, C.
    Diaz, G.
    Rodriguez, B.
    Cordoba, M. D. M.
    Provencio Pulla, M.
    ANNALS OF ONCOLOGY, 2017, 28